At the time of writing, Agilon Health Inc [AGL] stock is trading at $1.95, down -2.50%. An important factor to consider is whether the stock is rising or falling in short-term value. The AGL shares have lost -2.01% over the last week, with a monthly amount glided 24.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Bernstein started tracking the stock with Mkt Perform rating on December 11, 2024, and set its price target to $2.50. On November 11, 2024, downgrade downgraded it’s rating to Mkt Perform. William Blair downgraded its rating to a Mkt Perform. Citigroup downgraded its rating to a Sell and reduced its price target to $2.50 on October 30, 2024. BofA Securities downgraded its rating to Underperform for this stock on October 02, 2024, but kept the price target unchanged to $3. In a note dated May 30, 2024, Robert W. Baird initiated an Neutral rating and provided a target price of $6 on this stock.
For the past year, the stock price of Agilon Health Inc fluctuated between $1.50 and $13.45. Currently, Wall Street analysts expect the stock to reach $3.17 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $1.95 at the most recent close of the market. An investor can expect a potential return of 62.56% based on the average AGL price forecast.
Analyzing the AGL fundamentals
According to Agilon Health Inc [NYSE:AGL], the company’s sales were 5.59B for trailing twelve months, which represents an 19.35% jump. Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.5 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.85 points at the first support level, and at 1.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.10, and for the 2nd resistance point, it is at 2.25.
Ratios To Look Out For
It is important to note that Agilon Health Inc [NYSE:AGL] has a current ratio of 1.29. On the other hand, the Quick Ratio is 1.29, and the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 0.14, the price to book ratio is 1.40.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
